May 27, 2020 | Press Release
CARY, N.C., May 27, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, will be the exclusive specialty pharmacy provider for Pemazyre™ (pemigatinib), Incyte’s selective fibroblast growth factor receptor... May 8, 2020 | Press Release
CARY, N.C., May 8, 2020—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, was selected by Immunomedics, Inc. as a specialty pharmacy provider for TRODELVY™ (sacituzumab govitecan-hziy) for the treatment of... 